Pfizer, Endo Pay $50 Million to End Fraud Investigations

Generic Line
A A
Pfizer and Endo will each pay $25 million to resolve claims the companies overcharged Texas’ Medicaid program for generic drugs.

To View This Article:

Login

Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00